Health Care & Life Sciences » Biotechnology | Emergent Biosolutions Inc.

Emergent Biosolutions Inc.

Emergent Biosolutions Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
50.02 M
Public Float
42.07 M
Emergent Biosolutions Inc.
Stock Exchange New York Stock Exchange
EPS
$0.81
Market Cap
$2.34 B
Shares Outstanding
51.4 M
Public Float
42.67 M

Profile

Address
400 Professional Drive
Gaithersburg Maryland 20879
United States
Employees -
Website http://www.emergentbiosolutions.com
Updated 07/08/2019
Emergent BioSolutions Inc. engages in the development, manufacture, and commercialization of medical countermeasures that address public health and national security threats. It includes Chemical, Biological, Radiological, Nuclear and Explosive or CBRNE threats; as well as emerging infectious diseases. Its business units include Vaccines and Anti-Infectives; Antibody Therapeutics; Devices; and Contract Development and Manufacturing.

Financials

View All

Fuad El-Hibri
Executive Chairman
Daniel J. Abdun-Nabi
Chief Executive Officer & Director